C5ORF28 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.915600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.577400E-01
Normal-vs-Stage2
5.752200E-01
Normal-vs-Stage3
3.618300E-02
Normal-vs-Stage4
8.856800E-01
Stage1-vs-Stage2
3.903000E-01
Stage1-vs-Stage3
3.391700E-02
Stage1-vs-Stage4
8.860400E-01
Stage2-vs-Stage3
5.745700E-02
Stage2-vs-Stage4
3.611000E-01
Stage3-vs-Stage4
1.359610E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.521600E-01
Normal-vs-AfricanAmerican
7.945200E-01
Normal-vs-Asian
8.862000E-01
Caucasian-vs-AfricanAmerican
7.419400E-01
Caucasian-vs-Asian
4.639200E-01
AfricanAmerican-vs-Asian
8.837400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.757200E-01
Normal-vs-Female
7.404800E-01
Male-vs-Female
2.425200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.711400E-01
Normal-vs-Age(41-60Yrs)
8.126200E-01
Normal-vs-Age(61-80Yrs)
5.309400E-01
Normal-vs-Age(81-100Yrs)
4.791200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.838800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.215200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.788400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.405370E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.955000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.092200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.316800E-01
Normal-vs-Daily Drinker
3.230400E-01
Normal-vs-Weekly Drinker
8.626600E-01
Normal-vs-Occasional Drinker
8.976600E-01
Normal-vs-Social Drinker
6.580000E-01
Non Drinker-vs-Daily Drinker
4.855200E-01
Non Drinker-vs-Weekly Drinker
4.621600E-01
Non Drinker-vs-Occasional Drinker
1.285630E-01
Non Drinker-vs-Social Drinker
6.661200E-01
Daily Drinker-vs-Weekly Drinker
2.105200E-01
Daily Drinker-vs-Occasional Drinker
3.416100E-02
Daily Drinker-vs-Social Drinker
2.952400E-01
Weekly Drinker-vs-Occasional Drinker
5.977400E-01
Weekly Drinker-vs-Social Drinker
7.528800E-01
Occasional Drinker-vs-Social Drinker
3.195400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.442000E-01
Normal-vs-Grade 2
9.586000E-01
Normal-vs-Grade 3
9.755400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.957000E-01
Grade 1-vs-Grade 3
6.162400E-01
Grade 1-vs-Grade 4
9.442000E-01
Grade 2-vs-Grade 3
6.803600E-01
Grade 2-vs-Grade 4
9.586000E-01
Grade 3-vs-Grade 4
9.755400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.476800E-01
Normal-vs-NonDiabetic
6.672200E-01
Diabetic-vs-NonDiabetic
3.175500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.977400E-01
Normal-vs-NoPancreatitis
6.104200E-01
Pancreatitis-vs-NoPancreatitis
3.229400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.235000E-01
Normal-vs-N1
5.918600E-01
N0-vs-N1
8.876400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.097000E-01
Normal-vs-TP53-NonMutant
7.400800E-01
TP53-Mutant-vs-TP53-NonMutant
5.762400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
